CEO Lars Jørgensen is stepping down from his post after eight years in the role, during which he lead the company to an ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

U.S.-listed shares of Novo Nordisk declined in premarket trading Friday on the surprise news that CEO Lars Fruergaard ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

Danish pharmaceutical giant Novo Nordisk is saying goodbye to its chief executive amid growing competition for its ...

GEMMA Collins revealed she is slimming down faster than ever as she updated fans on her health journey. The TOWIE star, 44, has gone from a size 26 to a size 20 in just three-months since starting ...

Ozempic was approved to treat Type 2 diabetes in 2017, and it’s become increasingly popular among those who don’t have the ...

The drug is set to be available on the NHS for weight loss soon, but one expert has flagged some potential risks that come with it.

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...

Popular drugs for weight loss are now being prescribed to kids as young as 12. It’s been nearly two years since the FDA approved their use in kids, but some are questioning if these drugs are safe for ...

A recent study showed that well-known diabetes and weight loss drugs such as Ozempic and Wegovy do not raise the risk of ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a drug ...